GLAXO SMITH KLINE
Viés de alta

BICO risen from 27 to 41 in 5 months

Rapid change with almost certain assistance from its parent company
What happened during the past period is like a miracle. The company transformed after the first quarter results showed huge losses and embezzlement charges that resulted in restructuring.
After the distribution of closed dividends per share was suspended at 0.75 until liquidity was available, and liquidity was available quickly. I believe that financing was provided by the parent company in exchange for an export share and benefiting from the currency difference after the delay in the Medicine Authority’s decision to move the exchange rate.
The pending dividends were issued to shareholders and we await the second-quarter results, which look promising
I expect the stock to rise to 30 pounds during the month of 8, and the trend is towards 40 in January 2025.
BIOCEGX100Fundamental AnalysisGSK

Aviso legal